Finally, assuming microglial activation secondary to mTOR-driven malformations of cortical development in TSC, depletion of resident microglia, and repopulation of the brain with fresh microglia might offer a drastic, yet promising therapeutic option to resolve chronic neuroinflammation (231). Here, MTOR is linked to tuberous sclerosis.